SH2D3C and cancer: In addition, other genes have been involved in cancer processes, such as interference with innate immune system (SH2D3C), apoptosis (BLCAP), crossing-over regulation during meiosis (RNF212), and tumor suppression (ZDHHC14, MIR138-2, and PHTF1).